Early Remdesivir Linked to Lower COVID-19 Death Risk in Hospitalized Patients
Early administration of the intravenous antiviral drug remdesivir is linked to an approximate 25 percent reduction in the 28-day risk of death among hospitalized patients, particularly those with underlying kidney ... Read More